Ignite Creation Date:
2024-05-05 @ 5:13 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00419224
Status:
COMPLETED
Last Update Posted:
2007-01-11
First Post:
2007-01-05
Brief Title:
Influenza Vaccination in Bone Marrow Transplantation
Sponsor:
The Cleveland Clinic
Organization:
The Cleveland Clinic
Study Overview
Official Title:
Immunogenicity of Influenza Vaccination Flu Vac in Patients Receiving Nonmyeloablative Allogeneic Peripheral Blood Stem Cell Transplantation NM Allo PBSCT Compared to Healthy Controls
Status:
COMPLETED
Status Verified Date:
2007-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether influenza vaccination protects patients who receive a certain type of bone marrow transplantation
Detailed Description:
Patients who receive bone marrow transplantation are at high risk for complications from influenza infection It is not whether influenza vaccination protects patients who undergo a type of bone marrow transplantation called nonmyeloablative or reduced intensity bone marrow transplantation This study compares the response to influenza vaccination in a group of these patients to that in healthy people
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| RPC 6817 | None | None | None |